POINT Biopharma Announces First Patients Dosed in Phase 3 Study of PNT2002 for mCRPC

NEXT STORY
Global Zika Virus Market Pipeline Spotlight Report 2021
PREV STORY
Women’s Health Diagnostics Market Research Report by Type, by Application, by End User, by Region – Global Forecast to 2026 – Cumulative Impact of COVID-19
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Cempra Completes NDA Submissions for Solithromycin in the Treatment of Community-Acquired Bacterial Pneumonia

Solithromycin is designated by FDA as a Qualified Infectious Disease Product FDA has granted ...

author_avatar
NASDAQ Market News

Sensus Healthcare Expects Record 4Q 2021 Sales and Continued Growth in 1Q 2022; Profiles New Product at the 2022 Winter Clinical Dermatology Conference

author_avatar
NASDAQ Market News

Synairgen announces data from Home Cohort of SG016 Phase II trial of inhaled interferon beta in COVID-19 patients and encouraging combined data for whole SG016 trial

author_avatar
NASDAQ Market News